A sensitive bioanalytical method development and validation of cabozantinib in human plasma by LC-ESI-MS/MS. Braz. J. Pharm. Sci. [Internet]. 2018 Jul. 26 [cited 2024 May 9];54(2):e17163. Available from: https://www.revistas.usp.br/bjps/article/view/153781